The Rocky Sleep Study
Launched by UNIVERSITY OF BRITISH COLUMBIA · Apr 6, 2009
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Background: Infant behavioural sleep problems affect up to 50% of infants, can persist, and can contribute to adverse developmental outcomes. Persistent short night sleep periods from 5-to 29 months of age have been associated with more hyperactivity and inattention, and lower abilities at cognitive tasks for older children. Sleep problems in infants are also associated with parental stress, fatigue and family tension, and maternal depression. Health care professionals often fail to recognize and treat infant sleep problems and over 40 books and many websites provide conflicting advice. Int...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parents and their healthy 5.5 to 8 month-old infants.
- • Infants are waking 2 or more times per night or more than 20 minutes for at least 4 nights per week for a minimum of 3 weeks.
- • Parents are biological or have adopted their infants, can speak and read English, have access to a telephone and are in two or one parent families.
- Exclusion Criteria:
- • Infants are excluded who have biological causes of sleep problems, developmental disability, and/or chronic neurological or respiratory conditions.
- • Parents are excluded who have diagnosed depression and are receiving treatment, have diagnosed sleep problems (e.g. sleep apnea), and are working permanent night shifts.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, British Columbia, Canada
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Wendy Hall, RN, PhD
Principal Investigator
University of British Columbia
Radhika Bhagat, RN, MN
Study Director
Vancouver Coastal Health
Rollin Brant, Ph.D
Study Director
Centre for Community Child Health Research
Jean Paul Collett, Ph.D
Study Director
Child and Family Research Institute
Amiram Gafni, Ph.D
Study Director
McMaster University
Dorothy Hamilton, RN, BSN
Study Director
Vancouver Coastal Health
Eileen Hutton, Ph.D
Study Director
McMaster University
Kathy Hydamaka, RN, BSN
Study Director
Vancouver Coastal Health
Osman Ipsiroglu, MD
Study Director
Sunny Hill Health Centre for Children
Valerie Munroe, RN, MSN
Study Director
Vancouver Coastal Health Research Institute
Roy Saunders, MD
Study Director
Seymour Medical Clinic
Kathy Triolet, RN, BSN
Study Director
Vancouver Coastal Health
Lillian Tse, RN, MSN
Study Director
Vancouver Coastal Health
Joanne Wooldridge, RN, MSN
Study Director
Vancouver Coastal Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials